Myriad Genetics |
Data / Laikas | / |
Pok. / Pok.(%) | - / |
Bid | - |
Ask | - |
Atidaryti | - |
Ankstesnį uždaryti | - |
Aukšč. | - |
Žem. | - |
APYVARTA [USD] | - |
APYVARTA [Units] | |
Price fixings | |
ISIN | US62855J1043 |
Simbolis | MYGN |
Birža | IEX |
Rūšis | Stock |
Visos biržos
Birža | Paskutinis | APYVARTA | |
---|---|---|---|
Hannover | 21,420 | ![]() |
0 |
Frankfurt | 21,3900 | ![]() |
0 |
Berlin | 21,410 | ![]() |
0 |
München | 21,390 | ![]() |
0 |
Hamburg | 21,420 | ![]() |
0 |
Düsseldorf | 21,450 | ![]() |
0 |
Lang & Schwa.. | 21,390 | ![]() |
|
Stuttgart | 21,400 | ![]() |
|
gettex | 21,420 | ![]() |
|
Quotrix | 21,4900 | ![]() |
|
NASDAQ | 22,6500 | ![]() |
425.879 |
IEX | 22,65 | ![]() |
23.929 |
Cboe US | 22,65 | 9.703 | |
Xetra | 21,300 | 0 | |
TradeGate | 19,025 | 400 | |
London Domes.. | 23,39 | 140 |
Naujienos
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Click on
to activate push quotes.
